Fractus Takes Legal Action Against ResMed Over Patent Violations for Sleep Apnea Devices

Fractus Initiates Patent Infringement Lawsuit Against ResMed

Fractus, a leader in advanced antenna technology and intellectual property licensing, has recently announced its legal pursuit against ResMed, a prominent player in sleep apnea therapy solutions. The complaint was lodged in the Southern District of California, specifically alleging that ResMed's devices and connected therapy options are infringing upon several patents held by Fractus, which focus on innovative miniaturized multi-band antenna technologies.

Fractus’s CEO, Jordi Ilario, commented on the significance of this legal action, stating that the company has dedicated years to research and development aimed at enhancing wireless connectivity across various sectors. He emphasized the importance of protecting their intellectual property rights against unauthorized use. "When companies exploit our patented innovations without proper licensing, it undermines not just our business but the integrity of innovation as a whole," Ilario noted during a press conference.

Ruben Bonet, Executive Chairman of Fractus, supported this sentiment, highlighting the critical nature of connectivity in digital health solutions like remote patient monitoring. He articulated Fractus's objective to safeguard the foundational value of their inventions, enabling ongoing advancements in health technology based on fair licensing practices.

Representing Fractus in this case is Kobre & Kim LLP, with a team of seasoned attorneys led by Michael Ng, Daniel Zaheer, and George Stamatopoulos, who are recognized for their expertise in intellectual property litigation. Mr. Ng expressed enthusiasm about working with Fractus, aiming to deliver restitution for its impactful technological contributions, which play a pivotal role in improving the lives of patients across the globe.

About Fractus

Fractus has been at the forefront of innovating antenna design through the application of advanced geometry and mathematical principles. The company boasts a robust portfolio of over 40 patented inventions. Their antenna technology is integrated into smartphones, IoT devices, and various applications in the health sector, including connected medical devices. The reliability and performance of Fractus's inventions have earned the trust of numerous leading companies worldwide, complementing Fractus's accolades such as being named a Technology Pioneer by the World Economic Forum in 2005 and receiving the European Inspiring Company Award from the London Stock Exchange Group in 2017.

The ongoing case between Fractus and ResMed not only underscores the importance of patent adherence within technology sectors but also highlights a broader dialogue regarding the commercialization of technology in health care. As the intersection between technology and health continues to evolve, the legal outcomes of such cases will likely influence how companies approach innovation and licensing in the future.